F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder

Name of the Condition

• Other Psychoactive Substance Dependence with Other Psychoactive Substance-Induced Disorder
• ICD-10 Code: F19.288

Summary

This condition involves a pattern of dependence on non-classified psychoactive substances (excluding alcohol, opioids, or cannabis) that is complicated by co-occurring substance-induced disorders. Dependence is marked by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences. The induced disorder may include symptoms directly resulting from the substance's pharmacological effects, such as mood, anxiety, or psychotic symptoms.

Causes

The causes include chronic use of psychoactive substances that alter brain function, psychological factors such as stress or trauma, and social influences like peer pressure. The addictive potential of these substances, combined with repeated use, can lead to dependence. Induced disorders arise from the direct pharmacological effects of the substance on the central nervous system.

Risk Factors

• Genetic predisposition to addiction
• Co-occurring mental health disorders (e.g., anxiety, depression)
• Early exposure to psychoactive substances
• Environmental factors (e.g., access to substances, social norms)

Symptoms

• Intense cravings or urges to use the substance
• Inability to reduce or control use despite efforts
• Withdrawal symptoms when use is reduced or stopped
• Substance-induced symptoms (e.g., mood changes, anxiety, or other disorders)

Diagnosis

Diagnosis requires a clinical evaluation to confirm dependence criteria (e.g., tolerance, withdrawal, compulsive use) and identify substance-induced symptoms. A detailed history of substance use, including type, frequency, and duration, is essential. Laboratory tests or screening tools may support the assessment, but diagnosis relies on clinical judgment to distinguish dependence from other conditions.

Treatment Options

Treatment typically involves a combination of behavioral therapies (e.g., cognitive-behavioral therapy) and pharmacological interventions to manage withdrawal or co-occurring symptoms. Supportive care, such as counseling or peer support groups, may also be recommended. Treatment plans are individualized based on the substance involved and the severity of dependence.

Prognosis and Follow-Up

Prognosis varies depending on the substance, duration of use, and presence of co-occurring disorders. Long-term follow-up is often necessary to monitor for relapse and address ongoing symptoms. Early intervention and adherence to treatment improve outcomes, but recovery may be challenging due to the chronic nature of dependence.

Complications

Complications may include worsening of co-occurring mental health disorders, physical health issues (e.g., organ damage), social or occupational impairment, and increased risk of overdose. Substance-induced disorders can exacerbate dependence and hinder recovery efforts.

Lifestyle & Prevention

Lifestyle modifications, such as avoiding triggers and building a support network, may help prevent relapse. Prevention strategies include education about the risks of psychoactive substance use and addressing underlying factors like stress or trauma. Early intervention for at-risk individuals can reduce the likelihood of developing dependence.

When to Seek Professional Help

Seek professional help if there are signs of dependence (e.g., inability to control use, withdrawal symptoms) or if substance use is causing negative consequences in daily life. Prompt evaluation is important for managing symptoms and preventing complications.

Tips for Medical Coders

Document the specific psychoactive substance involved and the nature of the induced disorder (e.g., mood, anxiety) to support accurate coding. Ensure clinical notes reflect the presence of both dependence and the substance-induced disorder to justify the F19.288 code. Verify that the substance is classified as "other" (excluding alcohol, opioids, or cannabis) and that the induced disorder is directly attributable to its use.